A webcast of the presentation can be found under the IR Events tab of the Tonix website at .

Tonix Pharmaceuticals (NASDAQ: TNXP) announced the first patient has been dosed in the Phase 2 OASIS trial evaluating TNX-102 SL for reducing acute s ...

Yale scientists find nasal boosters may offer stronger, longer-lasting protection against COVID-19 by targeting immune ...

Scientists from Yale University have found that nasal vaccine boosters can be safer than vaccinations, may be safer to use, and help target better protection against respiratory diseases like COVID-19 ...

Investigator-initiated Phase 2 trial to evaluate TNX-102 SL's potential to reduce severity of acute stress reaction (ASR) and ...

To understand the mechanism of the nasal vaccines, the researchers first injected mice with a traditional mRNA COVID-19 shot, ...

Most vaccines -- and boosters -- are injected directly into muscle tissue, usually in the upper arm, to kickstart the body's immune system in the fight against disease. But for respiratory diseases ...

When scientists engineer a better way to fight the flu, they often begin with nature’s own defenses. That’s what a new study from researchers at The Ohio State University set out to do. Their goal was ...

NEW YORK (AP) — Columbia University said Tuesday that it will be laying off nearly 180 staffers in response to President Donald Trump’s decision to cancel $400 million in funding over the ...

NEW YORK (AP) — Columbia University said Tuesday that it will be laying off nearly 180 staffers in response to President Donald Trump’s decision to cancel $400 million in funding over the ...

The work impacted ranges from a project to develop an antiviral nasal spray for infectious diseases to various scientific studies on maternal mortality and morbidity, treatments for chronic ...